novel affinity tuned CAR-T / AffyImmune Therap - LARVOL DELTA

AffyImmune Therapeutics to Present Initial Clinical Results at Upcoming CAR-TCR Summit (PRNewswire) - "AffyImmune Therapeutics...announced today that scientific co-founder Moonsoo Jin will present twice at Hanson Wade's 6th CAR-TCR Summit being held virtually August 30 – September 2....Dr. Jin's first presentation 'Developing Manufacturing and Quality Control Platforms for Cell Immunotherapy' will occur as part of the CAR-TCR 101 Deep Dive Day Bootcamp at 1:30 pm EST on August 30....His second presentation 'First in Patient Clinical Readouts for Affinity Tuned CAR T with Real-Time Monitoring of Response' is part of the Clinical Management track on September 1 at 2:30 pm EST."

Preclinical • Oncology